Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation

被引:173
作者
Kanda, S [1 ]
Bishop, JF [1 ]
Eglitis, MA [1 ]
Yang, Y [1 ]
Mouradian, MM [1 ]
机构
[1] NINDS, Genet Pharmacol Unit, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA
关键词
Parkinson's disease; alpha-synuclein; oxidative stress; neuron; cell death;
D O I
10.1016/S0306-4522(00)00077-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synuclein is a key component of Lewy bodies found in the brains of patients with Parkinson's disease and two point mutations in this protein, Ala53Thr and Ala30Pro, are associated with rare familial forms of the disease. Several lines of evidence suggest the involvement of oxidative stress in the pathogenesis of nigral neuronal death in Parkinson's disease. In the present work we studied the effects of changes in the alpha-synuclein sequence on the susceptibility of cells to reactive oxygen species. Human dopaminergic neuroblastoma SH-SY5Y cells were stably transduced with various isoforms of a-synuclein and their survival following exposure to hydrogen peroxide or to the dopaminergic neurotoxin MPP+ was assessed. Cells expressing the two point mutant isoforms of alpha-synuclein were significantly more vulnerable to oxidative stress, with the Ala53Thr engineered cells faring the worst. In addition, cells expressing C-terminally truncated alpha-synuclein, particularly the 1-120 residue protein, were more susceptible than control beta-galactosidase engineered cells. The present experiments indicate that point mutations and C-terminal truncation of a-synuclein exaggerate the susceptibility of dopaminergic cells to oxidative damage. Thus, these observations provide a pathogenetic link between alpha-synuclein aberrations and a putative cell death mechanism in Parkinson's disease. (C) 2000 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:279 / 284
页数:6
相关论文
共 28 条
  • [1] Alam ZI, 1997, J NEUROCHEM, V69, P1326
  • [2] Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
    Alam, ZI
    Jenner, A
    Daniel, SE
    Lees, AJ
    Cairns, N
    Marsden, CD
    Jenner, P
    Halliwell, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1196 - 1203
  • [3] Baba M, 1998, AM J PATHOL, V152, P879
  • [4] Degradation of α-synuclein by proteasome
    Bennett, MC
    Bishop, JF
    Leng, Y
    Chock, PB
    Chase, TN
    Mouradian, MM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) : 33855 - 33858
  • [5] BIEDLER JL, 1978, CANCER RES, V38, P3751
  • [6] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [7] Synthetic filaments assembled from C-terminally truncated α-synuclein
    Crowther, RA
    Jakes, R
    Spillantini, MG
    Goedert, M
    [J]. FEBS LETTERS, 1998, 436 (03) : 309 - 312
  • [8] Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
    Cummings, CJ
    Reinstein, E
    Sun, YL
    Antalffy, B
    Jiang, YH
    Ciechanover, A
    Orr, HT
    Beaudet, AL
    Zoghbi, HY
    [J]. NEURON, 1999, 24 (04) : 879 - 892
  • [9] Widespread alterations of α-synuclein in multiple system atrophy
    Dickson, DW
    Liu, WK
    Hardy, J
    Farrer, M
    Mehta, N
    Uitti, R
    Mark, M
    Zimmerman, T
    Golbe, L
    Sage, J
    Sima, A
    D'Amato, C
    Albin, R
    Gilman, S
    Yen, SH
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) : 1241 - 1251
  • [10] Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease
    El-Agnaf, OMA
    Jakes, R
    Curran, MD
    Wallace, A
    [J]. FEBS LETTERS, 1998, 440 (1-2) : 67 - 70